Ultragenyx Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Ultragenyx Stock Summary

Ultragenyx competes with X4 Pharmaceuticals, Terns Pharmaceuticals, Day One, PDS Biotechnology, and Inozyme Pharma. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Ultragenyx Pharmaceutical Inc. was incorporated in 2010 and is headquartered in Novato, California. Ultragenyx Pharmaceu operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1119 people.

Ultragenyx Key Financial Ratios

Ultragenyx Key Balance Sheet Accounts

Ultragenyx Key Income Statement Accounts

Ultragenyx Key Cash Accounts

Ultragenyx Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ultragenyx's current stock value. Our valuation model uses many indicators to compare Ultragenyx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ultragenyx competition to find correlations between indicators driving Ultragenyx's intrinsic value. More Info.Ultragenyx is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Ultragenyx's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Ultragenyx by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Ultragenyx Systematic Risk

Today, most investors in Ultragenyx Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ultragenyx's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ultragenyx growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Ultragenyx help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ultragenyx. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ultragenyx based on widely used predictive technical indicators. In general, we focus on analyzing Ultragenyx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ultragenyx's daily price indicators and compare them against related drivers.

When running Ultragenyx's price analysis, check to measure Ultragenyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultragenyx is operating at the current time. Most of Ultragenyx's value examination focuses on studying past and present price action to predict the probability of Ultragenyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultragenyx's price. Additionally, you may evaluate how the addition of Ultragenyx to your portfolios can decrease your overall portfolio volatility.